δ-Opioid receptor as a potential therapeutic target for ischemic stroke

被引:0
|
作者
Kalpana Subedi [1 ]
Hongmin Wang [1 ]
机构
[1] Division of Basic Biomedical Sciences and Center for Brain and Behavior Research, Sanford School of Medicine, University of South Dakota
关键词
agonist; AKT; amyloid precursor protein; BDNF; ischemic stroke; neuroprotection; δ-opioid receptor; p38; MAPK; PI3K; TrkB;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
摘要
Ischemic stroke is a global epidemic condition due to an inadequate supply of blood and oxygen to a specific area of brain either by arterial blockage or by narrowing of blood vessels. Despite having advancement in the use of thrombolytic and clot removal medicine, significant numbers of stroke patients are still left out without option for treatment. In this review, we summarize recent research work on the activation of δ-opioid receptor as a strategy for treating ischemic stroke-caused neuronal injury. Moreover, as activation of δ-opioid receptor by a non-peptidic δ-opioid receptor agonist also modulates the expression, maturation and processing of amyloid precursor protein and β-secretase activity, the potential role of these effects on ischemic stroke caused dementia or Alzheimer’s disease are also discussed.
引用
收藏
页码:20 / 24
页数:5
相关论文
共 50 条
  • [1] δ-Opioid receptor as a potential therapeutic target for ischemic stroke
    Subedi, Kalpana
    Wang, Hongmin
    NEURAL REGENERATION RESEARCH, 2020, 15 (01) : 20 - 24
  • [2] AMPK: Potential Therapeutic Target for Ischemic Stroke
    Jiang, Shuai
    Li, Tian
    Ji, Ting
    Yi, Wei
    Yang, Zhi
    Wang, Simeng
    Yang, Yang
    Gu, Chunhu
    THERANOSTICS, 2018, 8 (16): : 4535 - 4551
  • [3] Tau as a potential therapeutic target for ischemic stroke
    Chen, Xin
    Jiang, Hua
    AGING-US, 2019, 11 (24): : 12827 - 12843
  • [4] Osteopontin as a Potential Therapeutic Target for Ischemic Stroke
    Zhu, Qiquan
    Luo, Xu
    Zhang, Jie
    Liu, Yun
    Luo, Hansheng
    Huang, Qin
    Cheng, Yuan
    Xie, Zongyi
    CURRENT DRUG DELIVERY, 2017, 14 (06) : 766 - 772
  • [5] Purinergic signaling: a potential therapeutic target for ischemic stroke
    Lu Wang
    Ying-Jie Li
    Xu Yang
    Bo Yang
    Xin Zhang
    Jing Zhang
    Qi Zhang
    Xu-Dong Cheng
    Jian-Hong Wang
    Neng-Wei Yu
    Purinergic Signalling, 2023, 19 : 173 - 183
  • [6] Tau as a Potential Novel Therapeutic Target in Ischemic Stroke
    Zheng, Guo-Qing
    Wang, Xiu-Min
    Wang, Yan
    Wang, Xiao-Tong
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2010, 109 (01) : 26 - 29
  • [7] Mitochondrial Dynamics: A Potential Therapeutic Target for Ischemic Stroke
    Zhou, Xiangyue
    Chen, Hanmin
    Wang, Ling
    Lenahan, Cameron
    Lian, Lifei
    Ou, Yibo
    He, Yue
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [8] Purinergic signaling: a potential therapeutic target for ischemic stroke
    Wang, Lu
    Li, Ying-Jie
    Yang, Xu
    Yang, Bo
    Zhang, Xin
    Zhang, Jing
    Zhang, Qi
    Cheng, Xu-Dong
    Wang, Jian-Hong
    Yu, Neng-Wei
    PURINERGIC SIGNALLING, 2023, 19 (01) : 173 - 183
  • [9] Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke
    Shen, Zihuan
    Xiang, Mi
    Chen, Chen
    Ding, Fan
    Wang, Yuling
    Shang, Chang
    Xin, Laiyun
    Zhang, Yang
    Cui, Xiangning
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 151
  • [10] The α2δ-1-NMDA receptor complex and its potential as a therapeutic target for ischemic stroke
    Wu, Tao
    Chen, Shao-Rui
    Pan, Hui-Lin
    Luo, Yi
    FRONTIERS IN NEUROLOGY, 2023, 14